AMLX
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock annual/quarterly cash on hand history from 2021 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for the quarter ending December 31, 2025 were 226.7M, a 192.86% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2025 were 226.7M, a 192.86% increase from 2024.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2024 were 77.4M, a 54.53% decrease from 2023.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2023 were 170.2M, a 172.21% increase from 2022.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2022 were 62.5M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Amylyx Pharmaceuticals, Inc. Common Stock Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $227 |
| 2024 | $77 |
| 2023 | $170 |
| 2022 | $63 |
| 2021 | $50 |
| Amylyx Pharmaceuticals, Inc. Common Stock Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $227 |
| 2024-12-31 | $77 |
| 2023-12-31 | $170 |
| 2022-12-31 | $63 |
| 2021-12-31 | $50 |
Amylyx Pharmaceuticals, Inc. Common Stock Cash on Hand — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) cash on hand over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's cash on hand history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's cash on hand by year and by quarter, including the growth rate.